|
| lucidenic acid N Basic information |
Product Name: | lucidenic acid N | Synonyms: | lucidenic acid N;Lucidenic acid LM1;Lucideric acid SP1;Lucidenic acid SP1;(3beta,5alpha,7beta)-3,7-dihydroxy-4,4,14-trimethyl-11,15-dioxochol-8-en-24-oic acid;Chol-8-en-24-oic acid, 3,7-dihydroxy-4,4,14-trimethyl-11,15-dioxo-, (3β,5α,7β)-;Lucidenic acid SP1 (Lucidenic acid LM1) | CAS: | 364622-33-3 | MF: | C27H40O6 | MW: | 460.6 | EINECS: | | Product Categories: | Triterpenoids;chemical reagent;pharmaceutical intermediate;phytochemical;reference standards from Chinese medicinal herbs (TCM).;standardized herbal extract | Mol File: | 364622-33-3.mol | ![lucidenic acid N Structure](CAS/20180906/GIF/364622-33-3.gif) |
| lucidenic acid N Chemical Properties |
Melting point | 202-204 °C | Boiling point | 640.7±55.0 °C(Predicted) | density | 1.22±0.1 g/cm3(Predicted) | pka | 4.72±0.10(Predicted) | form | Solid | color | White to off-white |
| lucidenic acid N Usage And Synthesis |
Definition | ChEBI: Lucidenic acid N is a tetracyclic triterpenoid that is 25,26,27-trinorlanost-8-en-24-oic acid substituted by hydroxy groups at positions 3 and 7 and oxo groups at positions 11 and 15 respectively (the 3beta,5alpha,7beta stereoisomer). Isolated from the fruiting bodies of Ganoderma lucidum, it exhibits cytotoxicity against tumour cells. It has a role as a metabolite, an EC 3.1.1.8 (cholinesterase) inhibitor and an antineoplastic agent. It is a tetracyclic triterpenoid, a cyclic terpene ketone, a dioxo monocarboxylic acid and a secondary alcohol. |
| lucidenic acid N Preparation Products And Raw materials |
|